Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk
暂无分享,去创建一个
James P. Hughes | Connie Celum | Helen Rees | Carey Farquhar | Robert W. Coombs | Wendy S. Stevens | Lawrence Corey | Deborah Donnell | Anna Wald | J. Mullins | J. Baeten | H. Rees | A. Wald | J. Hughes | L. Corey | M. Essex | G. Gray | W. Stevens | D. Donnell | C. Farquhar | R. Coombs | J. Lingappa | C. Celum | M. Campbell | James I. Mullins | Jairam R. Lingappa | Richard S. Wang | Jared M. Baeten | Glenda E. Gray | Mary S. Campbell | M. Essex | H. S. team | J. Hughes
[1] James P. Hughes,et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. , 2010, The New England journal of medicine.
[2] T. Quinn,et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. , 2004, The Journal of infectious diseases.
[3] Christopher Dye,et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.
[4] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.
[5] S. Vermund,et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.
[6] Christophe Fraser,et al. HIV-1 transmission, by stage of infection. , 2008, The Journal of infectious diseases.
[7] Christophe Fraser,et al. Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load , 2009, AIDS.
[8] J. Overbaugh,et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial , 2008, AIDS.
[9] Connie Celum,et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. , 2007, The Journal of infectious diseases.
[10] Joep Lange,et al. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. , 2008, The Journal of clinical investigation.
[11] H. Rees,et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa , 2009, AIDS.
[12] Wendy S Stevens,et al. Challenges in implementing HIV load testing in South Africa. , 2010, The Journal of infectious diseases.
[13] Vincent Foulongne,et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. , 2007, The New England journal of medicine.
[14] S. Vermund,et al. Effect of treating co-infections on HIV-1 viral load: a systematic review. , 2010, The Lancet. Infectious diseases.
[15] J. Baeten,et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. , 2008, The Journal of infectious diseases.
[16] S. Vermund,et al. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression , 2008, AIDS.
[17] O. Laeyendecker,et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.
[18] T. Merigan,et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. , 1996, The New England journal of medicine.
[19] S. Whitehead,et al. Suppressive Acyclovir Therapy Reduces HIV Cervicovaginal Shedding in HIV- and HSV-2-Infected Women, Chiang Rai, Thailand , 2008, Journal of acquired immune deficiency syndromes.
[20] References , 1971 .
[21] D. Ho,et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. , 1995, The New England journal of medicine.
[22] S. Gurunathan,et al. Use of predictive markers of HIV disease progression in vaccine trials. , 2009, Vaccine.
[23] T. Quinn,et al. The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics , 2004, Journal of acquired immune deficiency syndromes.